drugset / Trial / NCT00064324

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00064324

Phase 2 Completed 46 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of perifosine in treating patients who have advanced soft tissue sarcoma. Drugs used in chemotherapy such as perifosine use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2003-06
Primary completion
2005-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Perifosine Small molecule Oral

Indications